PMH25 A COMPARISON OF THE COST-EFFECTIVENESS OF OLANZAPINE FOR THE TREATMENT OF SCHIZOPHRENIA IN SELECTED NON-OECD COUNTRIES
May 1, 2004, 00:00
10.1016/S1098-3015(10)62222-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)62222-X/fulltext
Title :
PMH25 A COMPARISON OF THE COST-EFFECTIVENESS OF OLANZAPINE FOR THE TREATMENT OF SCHIZOPHRENIA IN SELECTED NON-OECD COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62222-X&doi=10.1016/S1098-3015(10)62222-X
First page :
Section Title :
Open access? :
No
Section Order :
161